STA
INSP icon

Summit Trail Advisors’s Inspire Medical Systems INSP Stock Holding History

Summit Trail Advisors’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Buy
+6,712
New +$318K ﹤0.01% 1339

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Summit Trail Advisors's INSP Position: Q2 2026 in Review

Summit Trail Advisors opened a new position in Inspire Medical Systems (INSP) in Q2 2026: 6,712 shares worth $299K. The stake represents ﹤0.01% of the portfolio and ranks #1339 among its holdings.

275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Summit Trail Advisors held 6,712 shares of Inspire Medical Systems worth $299K as of Q2 2026.
  • Inspire Medical Systems was a new Summit Trail Advisors position in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of Summit Trail Advisors's portfolio in Q2 2026, its #1339 holding.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.